TGF-β Suppression of HBV RNA through AID-Dependent Recruitment of an RNA Exosome Complex

English version České info

HBV is one of the causative factors of hepatocellular carcinoma. Recent studies have shown that the members of the APOBEC deaminase family are antiviral factors that suppress the replication of viruses, such as HIV-1 and HBV. APOBEC3G suppresses viral replication by either hypermutation of nascent DNA or inhibition of reverse transcription. Recent studies have been suggested that AID, another APOBEC family member, restricts viruses and retrotransposons that use reverse transcription for their replication. However, little is known about the antiviral mechanisms of AID. TGF-β is a pleiotropic cytokine involved in the suppression of HBV replication, but the mechanism underlying its anti-HBV activity is unclear. In this study, we found that AID plays a role in the anti-HBV activity of TGF-β. Further study revealed that AID physically associates with a viral RNP complex containing reverse transcriptase and recruits the RNA degradosome (RNA exosome) to the RNP complex to degrade the viral RNA. To the best of our knowledge, this study is the first to reveal a novel antiviral pathway in which AID triggers viral RNA degradation by tethering the RNA exosome to the viral reverse transcriptase/RNA complex. Viral RNA may be another target for APOBEC antiviral activity.

Vyšlo v časopise: TGF-β Suppression of HBV RNA through AID-Dependent Recruitment of an RNA Exosome Complex. PLoS Pathog 11(4): e32767. doi:10.1371/journal.ppat.1004780
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1004780

Souhrn

Zdroje

1. Nguyen DH, Ludgate L, Hu J (2008) Hepatitis B virus-cell interactions and pathogenesis. J Cell Physiol 216 : 289–294. doi: 10.1002/jcp.21416 18302164

2. Nassal M (2008) Hepatitis B viruses: reverse transcription a different way. Virus Res 134 : 235–249. doi: 10.1016/j.virusres.2007.12.024 18339439

3. Harris RS, Liddament MT (2004) Retroviral restriction by APOBEC proteins. Nat Rev Immunol 4 : 868–877. 15516966

4. Malim MH (2009) APOBEC proteins and intrinsic resistance to HIV-1 infection. Philos Trans R Soc Lond B Biol Sci 364 : 675–687. doi: 10.1098/rstb.2008.0185 19038776

5. Goila-Gaur R, Strebel K (2008) HIV-1 Vif, APOBEC, and intrinsic immunity. Retrovirology 5 : 51. doi: 10.1186/1742-4690-5-51 18577210

6. Muramatsu M, Sankaranand VS, Anant S, Sugai M, Kinoshita K, et al. (1999) Specific expression of activation-induced cytidine deaminase (AID), a novel member of the RNA-editing deaminase family in germinal center B cells. J Biol Chem 274 : 18470–18476. 10373455

7. Muramatsu M, Kinoshita K, Fagarasan S, Yamada S, Shinkai Y, et al. (2000) Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 102 : 553–563. 11007474

8. Muramatsu M, Nagaoka H, Shinkura R, Begum NA, Honjo T (2007) Discovery of activation-induced cytidine deaminase, the engraver of antibody memory. Adv Immunol 94 : 1–36. 17560270

9. Di Noia JM, Neuberger MS (2007) Molecular mechanisms of antibody somatic hypermutation. Annu Rev Biochem 76 : 1–22. 17328676

10. Watashi K, Liang G, Iwamoto M, Marusawa H, Uchida N, et al. (2013) Interleukin-1 and tumor necrosis factor-alpha trigger restriction of hepatitis B virus infection via a cytidine deaminase AID. J Biol Chem 288 : 31715–31727. doi: 10.1074/jbc.M113.501122 24025329

11. Kou T, Marusawa H, Kinoshita K, Endo Y, Okazaki IM, et al. (2007) Expression of activation-induced cytidine deaminase in human hepatocytes during hepatocarcinogenesis. Int J Cancer 120 : 469–476. 17066440

12. Endo Y, Marusawa H, Kinoshita K, Morisawa T, Sakurai T, et al. (2007) Expression of activation-induced cytidine deaminase in human hepatocytes via NF-kappaB signaling. Oncogene 26 : 5587–5595. 17404578

13. Vartanian JP, Henry M, Marchio A, Suspene R, Aynaud MM, et al. (2010) Massive APOBEC3 Editing of Hepatitis B Viral DNA in Cirrhosis. PLoS Pathog 6: e1000928. doi: 10.1371/journal.ppat.1000928 20523896

14. MacDuff D, Demorest Z, Harris R (2009) AID can restrict L1 retrotransposition suggesting a dual role in innate and adaptive immunity. Nucleic Acids Res 37 : 1854–1867. doi: 10.1093/nar/gkp030 19188259

15. Metzner M, Jäck H, Wabl M (2012) LINE-1 Retroelements Complexed and Inhibited by Activation Induced Cytidine Deaminase. PLOS one 7: e49358. doi: 10.1371/journal.pone.0049358 23133680

16. Gourzi P, Leonova T, Papavasiliou FN (2006) A role for activation-induced cytidine deaminase in the host response against a transforming retrovirus. Immunity 24 : 779–786. 16782033

17. Bekerman E, Jeon D, Ardolino M, Coscoy L (2013) A Role for Host Activation-Induced Cytidine Deaminase in Innate Immune Defense against KSHV PLoS Pathog 9: e1003748. doi: 10.1371/journal.ppat.1003748 24244169

18. Karimi-Googheri M, Daneshvar H, Nosratabadi R, Zare-Bidaki M, Hassanshahi G, et al. (2014) Important roles played by TGF-beta in hepatitis B infection. Journal of Medical Virology 86 : 102–108. doi: 10.1002/jmv.23727 24009084

19. Shirai Y, Kawata S, Tamura S, Ito N, Tsushima H, et al. (1994) Plasma transforming growth factor-beta 1 in patients with hepatocellular carcinoma. Comparison with chronic liver diseases. Cancer 73 : 2275–2279. 7513247

20. Chou YC, Chen ML, Hu CP, Chen YL, Chong CL, et al. (2007) Transforming growth factor-beta1 suppresses hepatitis B virus replication primarily through transcriptional inhibition of pregenomic RNA. Hepatology 46 : 672–681. 17580335

21. Kim HY, Park GS, Kim EG, Kang SH, Shin HJ, et al. (2004) Oligomer synthesis by priming deficient polymerase in hepatitis B virus core particle. Virology 322 : 22–30. 15063113

22. Pontisso P, Vidalino L, Quarta S, Gatta A (2008) Biological and clinical implications of HBV infection in peripheral blood mononuclear cells. Autoimmun Rev 8 : 13–17. doi: 10.1016/j.autrev.2008.07.016 18706529

23. Coffin CS, Mulrooney-Cousins PM, Peters MG, van Marle G, Roberts JP, et al. (2011) Molecular characterization of intrahepatic and extrahepatic hepatitis B virus (HBV) reservoirs in patients on suppressive antiviral therapy. J Viral Hepat 18 : 415–423. doi: 10.1111/j.1365-2893.2010.01321.x 20626626

24. Nakamura M, Kondo S, Sugai M, Nazarea M, Imamura S, et al. (1996) High frequency class switching of an IgM+ B lymphoma clone CH12F3 to IgA+ cells. Int Immunol 8 : 193–201. 8671604

25. Faili A, Aoufouchi S, Gueranger Q, Zober C, Leon A, et al. (2002) AID-dependent somatic hypermutation occurs as a DNA single-strand event in the BL2 cell line. Nat Immunol 3 : 815–821. 12145648

26. Liang G, Kitamura K, Wang Z, Liu G, Chowdhury S, et al. (2013) RNA editing of hepatitis B virus transcripts by activation-induced cytidine deaminase. Proc Natl Acad Sci U S A 110 : 2246–2251. doi: 10.1073/pnas.1221921110 23341589

27. Ta VT, Nagaoka H, Catalan N, Durandy A, Fischer A, et al. (2003) AID mutant analyses indicate requirement for class-switch-specific cofactors. Nat Immunol 4 : 843–848. 12910268

28. Sun JB, Keim CD, Wang JG, Kazadi D, Oliver PM, et al. (2013) E3-ubiquitin ligase Nedd4 determines the fate of AID-associated RNA polymerase II in B cells. Genes & Development 27 : 1821–1833.

29. Basu U, Meng FL, Keim C, Grinstein V, Pefanis E, et al. (2011) The RNA exosome targets the AID cytidine deaminase to both strands of transcribed duplex DNA substrates. Cell 144 : 353–363. doi: 10.1016/j.cell.2011.01.001 21255825

30. Houseley J, LaCava J, Tollervey D (2006) RNA-quality control by the exosome. Nat Rev Mol Cell Biol 7 : 529–539. 16829983

31. Schmid M, Jensen TH (2008) The exosome: a multipurpose RNA-decay machine. Trends Biochem Sci 33 : 501–510. doi: 10.1016/j.tibs.2008.07.003 18786828

32. Preker P, Nielsen J, Kammler S, Lykke-Andersen S, Christensen MS, et al. (2008) RNA Exosome Depletion Reveals Transcription Upstream of Active Human Promoters. Science 322 : 1851–1854. doi: 10.1126/science.1164096 19056938

33. Stenglein MD, Burns MB, Li M, Lengyel J, Harris RS (2010) APOBEC3 proteins mediate the clearance of foreign DNA from human cells. Nat Struct Mol Biol 17 : 222–229. doi: 10.1038/nsmb.1744 20062055

34. Chowdhury S, Kitamura K, Simadu M, Koura M, Muramatsu M (2013) Concerted action of activation-induced cytidine deaminase and uracil-DNA glycosylase reduces covalently closed circular DNA of duck hepatitis B virus. Febs Letters 587 : 3148–3152. doi: 10.1016/j.febslet.2013.07.055 23954625

35. Sells M, Chen M, Acs G (1987) Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA. Proc Natl Acad Sci U S A 84 : 1005–1009. 3029758

36. Kochel HG, Kann M, Thomssen R (1991) Identification of a binding site in the hepatitis B virus RNA pregenome for the viral Pol gene product. Virology 182 : 94–101. 1708931

37. Mao R, Nie H, Cai D, Zhang J, Liu H, et al. (2013) Inhibition of hepatitis B virus replication by the host zinc finger antiviral protein. PLoS Pathog 9: e1003494. doi: 10.1371/journal.ppat.1003494 23853601

38. Kitamura K, Wang Z, Chowdhury S, Simadu M, Koura M, et al. (2013) Uracil DNA Glycosylase Counteracts APOBEC3G-Induced Hypermutation of Hepatitis B Viral Genomes: Excision Repair of Covalently Closed Circular DNA. Plos Pathogens 9: e1003361. doi: 10.1371/journal.ppat.1003361 23696735

39. Nguyen DH, Hu J (2008) Reverse transcriptase -⁠ and RNA packaging signal-dependent incorporation of APOBEC3G into hepatitis B virus nucleocapsids. J Virol 82 : 6852–6861. doi: 10.1128/JVI.00465-08 18480459

40. Doi T, Kinoshita K, Ikegawa M, Muramatsu M, Honjo T (2003) De novo protein synthesis is required for the activation-induced cytidine deaminase function in class-switch recombination. Proc Natl Acad Sci U S A 100 : 2634–2638. 12591955

41. Tsuge M, Hiraga N, Takaishi H, Noguchi C, Oga H, et al. (2005) Infection of human hepatocyte chimeric mouse with genetically engineered hepatitis B virus. Hepatology 42 : 1046–1054. 16250045

42. Lee DK, Park SH, Yi Y, Choi SG, Lee C, et al. (2001) The hepatitis B virus encoded oncoprotein pX amplifies TGF-beta family signaling through direct interaction with Smad4: potential mechanism of hepatitis B virus-induced liver fibrosis. Genes Dev 15 : 455–466. 11230153

43. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25 : 402–408. 11846609